MOMA Therapeutics operates as a biotechnology company. Founded by Dorothee Kern, Eva Nogales, and Johannes Walter in 2020, MOMA Therapeutics is backed by investors that include Casdin Capital, Cormorant Asset Management, Nextech Invest, Rock Springs Capital, and Third Rock Ventures and is headquartered in Cambridge.